Comportamiento de las enfermedades inflamatorias del intestino en el Servicio Provincial de Coloproctología de Camagüey
Abstract
Background: the inflammatory disease of the intestine defines like an inflammatory chronic affectation of the alimentary canal of unknown etiology that evolves of recurrent mode with sprouts and remissions and can present various complications and extra digestive manifestations.
Objective: to describe the behavior of the inflammatory diseases of the intestine in Provincial Colon-proctology Service of the Teaching Hospital Manuel Ascunce Domenech.
Methods: a descriptive cross-sectional study was carried out from April, 2016 to April, 2018. The universe of study was constituted for the 100 patients diagnosed by endoscopy’s studies and biopsy of inflammatory disease of the intestine in the aforementioned service. The investigation's primary source was given for a fill-out form designed by the authors.
Results: the patients diagnosed of ulcerous colitis occupied the first place with a predominance of age diagnosis between 30-39 years old, almost half of the studied patients presented familiar background of intestinal inflammatory disease, the distal localization showed the most frequent for the ulcerative idiopathic colitis, while for Crohn the most frequent localization was perinea localization with just a case; the clinical intestinal manifestation more frequent corresponded to the diarrheas.
Conclusions: the ulcerative colitis turned out to be more frequent than the disease of Crohn and then unspecified colitis with an age diagnosis between 30-39 years old; and with predominance of first-rate family record of the disease; in the ulcerative colitis prevailed the location distal and in the Crohn it was perineal being the diarrhea the most frequent symptom in both.
DeCS: INFLAMMATORY BOWEL DISEASES; COLORECTAL SURGERY; CROHN DISEASE; COLITIS, ULCERATIVE, DIARRHEA.
Downloads
References
1. Farreras Valenti P, Rotzman P. Medicina Interna de Farreras. Madrid, España: Elsevier; 2016.
2. Paniagua Estévez ME. Enfermedad de Crohn. En: Paniagua Estévez ME, Piñol Jiménez FN, editores. Gastroenterología y hepatología clínica. La Habana: ECIMED; 2016. p. 1355-1401.
3. Ng SC, Shi HY, Hamidi N, Underwood FE, Tang W, Benchiol EI, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet [Internet]. 2017 [citado 19 Oct 2020];390(10114):[aprox. 9 p.]. Disponible en: https://pubmed.ncbi.nlm.nih.gov/29050646/.
4. Ungaro R, Mehandru S, Allen PB, Peyrin-Biroulet L, Colombel JF. Ulcerative Colitis. Lancet [Internet]. 2017 [citado 19 Oct 2020];389(10080):[aprox. 14 p.]. Disponible en: https://doi.org/10.1016/S0140-6736(16)32126-2
5. Kotze PG, Underwood F, Damiao AOMC, Ferraz JG, Saad-Hossne R, Toro M, et al. Progression of Inflammatory Bowel Diseases Throughout Latin America and the Caribbean: A Systematic Review. Clin Gastroenterol Hepatol [Internet]. 2020 [citado 19 Oct 2020];18(2):[aprox. 8 p.]. Disponible en: https://doi.org/10.1016/j.cgh.2019.06.030
6. Wisniewski A, Kirchgesner J, Seksik P, Landman C, Bourrier A, Nion-Larmurier I, et al. Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines. United Eur Gastroenterol J [Internet]. 2020 [citado 19 Oct 2020];8(3):[aprox. 10 p.]. Disponible en: https://doi.org/10.1177/2050640619889763
7. Garg M, Royce SG, Tikellis C, Shallue C, Batu D, Velkoska E, et al. Imbalanceoftherenin-angiotensin system may contributeto inflammation and fibrosis in IBD: a novel therapeutictarget? Gut [Internet]. 2020 [citado 19 Oct 2020];69(5):[aprox. 10 p.]. Disponible en: http://dx.doi.org/10.1136/gutjnl-2019-318512
8. Fernández Maqueira G, Crespo Ramírez E, González Pérez S, Jerez Marimón D, García Capote E. Colitis Ulcerativa: una mirada al mundo. Rev Ciencias Médicas Pinar del Río [Internet]. May-Jun 2018 [citado 17 Feb 2019];22(3):[aprox. 9 p.]. Disponible en: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/3391/html
9. Lewis JD, Abreu M. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology [Internet]. 2017 [citado 19 Oct 2020];152:[aprox. 16 p.]. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S012099572015000500009&lng=es&nrm=is.&tlng=es
10. Díaz Alcázar MM, García Robles A, Martín-Lagos Maldonado A. La importancia del diagnóstico diferencial con infecciones intestinales en enfermedad inflamatoria intestinal: a propósito de un caso de giardiasis en paciente con sospecha de enfermedad de Crohn. RAPD Online [Internet]. 2019 [citado 19 Oct 2020];42(4):[aprox. 11 p.]. Disponible en: https://www.sapd.es/revista/2019/42/4/07
11. Hano García OM, Andrade Gomes S, Villa Jiménez OM, González Fabián L, Wood Rodríguez L. Caracterización de pacientes con enfermedad de Crohn atendidos en el Instituto de Gastroenterología de Cuba. Rev Cubana Invest Bioméd [Internet]. Jul-Sep 2014 [citado 24 May 2020];33(3):[aprox. 5 p.].Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002014000300001
12. Quera R, Palma R. Epidemiología de la enfermedad inflamatoria intestinal crónica en Gijón. Asturias. Rev Med Gijon [Internet]. 2015 [citado 19 Oct 2020];24(05):[aprox. 5 p.]. Disponible en: file:///C:/Users/ASUS/Downloads/mortalidad-enfermedad-inflamatoria-intestinal-cronica-gijon-asturias-aeg-2011-taiss.pdf
13. Laine L, Kaltenbach T, Barkun A, Mc Quaid KR, Subramanian V, Soetikno R, et al. SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease. Gastrointest Endosc [Internet]. 2015 [citado 04 Sept 2020];81(3):[aprox. 12 p.]. Disponible en: https://www.cag-acg.org/images/publications/SCENIC_consensus_statement.pdf
14. Mohammed N, Kant P, Abid F, Rotimi O, Prasad P, Hamlin JP, et al. High definition white light endoscopy (HDWLE) versus high definition with chromoendoscopy (HDCE) in the detection of dysplasia in long standing ulcerative colitis: a randomized controlled trial. Gastrointest Endosc [Internet]. 2015 [citado 24 Sep 2020];81(5):[aprox. 7 p.]. Disponible en: https://www.giejournal.org/article/S0016-5107(15)01460-1/abstract
15. Iacucci M, Gasia MF, Urbanski SJ, Parham M, Kaplan G, Panaccione R, et al. A randomised comparison of high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy using iSCAN for detection of colonic dysplastic lesions during IBD surveillance colonoscopy. Gastroenterology [Internet]. 2015 [citado 24 Sept 2020];148(4):[aprox. 8 p.]. Disponible en: https://www.gastrojournal.org/article/S0016-5085(15)30256-0/abstract
16. Riestra S, Castaño-García A, de Francisco R, Pérez-Martínez I. Enfermedad inflamatoria intestinal: aspectos prácticos para el médico de familia. Actualizando la práctica asistencial. FMC [Internet]. 2019 [citado 24 Sep 2020];26(4):[aprox. 9 p.]. Disponible en: https://www.researchgate.net/publication/332811295_Enfermedad_inflamatoria_intestinal_aspectos_practicos_para_el_medico_de_familia
17. Figueroa C, Quera R, Valenzuela J, Jensen C. Enfermedades Inflamatorias Intestinales: experiencia en dos centros chilenos. Rev Med Chile [Internet]. 2005 [citado 24 Sep 2020];133(11):[aprox. 9 p.]. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0034-98872005001100004
18. Sambuelli AM, Negreira S, Gil A, Goncalves S, Chavero P, Tirado P, et al. Manejo de la enfermedad inflamatoria intestinal. Revisión y algoritmos de tratamiento. Acta Gastroenterol Latinoam [Internet]. 2019 [citado 24 Sep 2020];49(Sº2):[aprox. 38 p.]. Disponible en: http://www.actagastro.org/numeros-anteriores/2019/Vol-49-S2/Vol49S2.pdf
19. Grez C, Ossa JC. Enfermedad infamatoria intestina en pediatría, una revisión. Rev Med Clin Condes [Internet]. 2019 [citado 24 Sep 2020];30(5):[aprox. 9 p.]. Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-pdf-S071686401930077X
20. Chao González L. Colitis ulcerosa. En: Paniagua Estévez ME, Piñol Jiménez FN, editores. Gastroenterología y hepatología clínica. La Habana: ECIMED; 2016. p. 1402-1446.
Published
How to Cite
Issue
Section
License
Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.
Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.
(Download Statement of potential conflicts of interest)
The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).
This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/
22 julio 2025